# Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome

> **NCT03059173** · PHASE3 · RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 276 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome
- Reproductive Medicine

## Interventions

- **DIETARY_SUPPLEMENT:** Myo-Inositol + Levomefolic acid
- **DRUG:** Clomiphene Citrate
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT03059173
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-12
- **Primary completion:** 2027-09-12
- **Final completion:** 2027-12
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03059173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03059173, "Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03059173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*